Reduction of Myocardial Infarct Size by Dronedarone in Pigs—A Pleiotropic Action?

PURPOSE: Dronedarone is a first-line drug to prevent the recurrence of atrial fibrillation according to ESC guidelines. In the recent ATHENA trial, dronedarone reduced mortality and also hospitalization for acute coronary syndrome in patients with atrial fibrillation. This beneficial effect suggests...

Descripción completa

Detalles Bibliográficos
Autores principales: Skyschally, Andreas, Heusch, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110275/
https://www.ncbi.nlm.nih.gov/pubmed/21544523
http://dx.doi.org/10.1007/s10557-011-6300-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110275/
https://www.ncbi.nlm.nih.gov/pubmed/21544523
http://dx.doi.org/10.1007/s10557-011-6300-1

Ejemplares similares